Biomet
Japan OKs $13B Zimmer-Biomet merger
BSX faces $50m gender suit | Medtech legal news for the week of March 23, 2015
Report: EU to clear Zimmer’s $13B Biomet deal
Feds extend Biomet’s deferred prosecution deal for another year
Biomet said yesterday that the U.S. Justice Dept. extended by a year the deferred prosecution agreement reached in 2012 over alleged violations of the Foreign Corrupt Practices Act.